Wound Treatments - Germany
2009 sales of wound treatments in Germany increased by almost 2% in current value terms, reaching over EUR78mn. Partly due to the relatively stable nature of the sector, little movement or growth have been observed during the review period.
Euromonitor International's Wound Treatments Products in Germany report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.
Product coverage:Other Wound Treatments, Sticking Plasters
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Euromonitor International's Wound Treatments Products in Germany report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.
Product coverage:Other Wound Treatments, Sticking Plasters
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Consumer Health industry;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Executive Summary
Expenditure on Consumer Health Slows Down Compared To Previous Years
OTC Obesity Drugs Enter Market
Main Brands Continue To Gain Importance
Distribution Channels Continue To Shift Slowly
Forecast Performance Expected To Remain Sluggish
Key Trends and Developments
Increased Obesity Rates Are Having A Positive Impact on Supplement Sales
Private Label Products Continue To Increase Market Share in Many Categories
Consumer Doubts Impact Sales of OTC Medicine
Increasing Trust in Homoeopathic Remedies Shifts Consumer Demand
European Court of Justice Stops Setting Up of Chemist/pharmacy Chains
Market Indicators
Table 1 Consumer Expenditure on Health Goods and Medical Services 2004-2009
Table 2 Life Expectancy at Birth 2004-2009
Market Data
Table 3 Sales of Consumer Health by Sector: Value 2004-2009
Table 4 Sales of Consumer Health by Sector: % Value Growth 2004-2009
Table 5 Consumer Health Company Shares by Value 2005-2009
Table 6 Consumer Health Brand Shares by Value 2006-2009
Table 7 Penetration of Private Label by Sector 2004-2009
Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2004-2009
Table 9 Sales of Consumer Health by Sector and Distribution Format: % Analysis 2009
Table 10 Forecast Sales of Consumer Health by Sector: Value 2009-2014
Table 11 Forecast Sales of Consumer Health by Sector: % Value Growth 2009-2014
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine (florian)
Switches
Summary 1 OTC Healthcare Switches 2007-2009
Definitions
Sector and Subsector Definitions
Summary 2 Research Sources
Bad Heilbrunner Naturheilmittel GmbH & Co
Strategic Direction
Key Facts
Summary 3 Bad Heilbrunner Naturheilmittel GmbH & Co: Key Facts
Summary 4 Bad Heilbrunner Naturheilmittel GmbH & Co: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 5 Bad Heilbrunner Naturheilmittel GmbH & Co: Competitive Position 2009
Bayer Vital GmbH
Strategic Direction
Key Facts
Summary 6 Bayer Vital GmbH: Key Facts
Summary 7 Bayer Vital GmbH: Operational Indicators
Company Background
Production
Summary 8 Bayer Vital AG: Production Statistics 2009
Competitive Positioning
Summary 9 Bayer Vital GmbH: Competitive Position 2009
Beiersdorf AG
Strategic Direction
Key Facts
Summary 10 Beiersdorf AG: Key Facts
Summary 11 Beiersdorf AG: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 12 Beiersdorf AG: Competitive Position 2009
Boehringer Ingelheim Pharma GmbH & Co Kg
Strategic Direction
Key Facts
Summary 13 Boehringer Ingelheim Pharma GmbH & Co KG: Key Facts
Summary 14 Boehringer Ingelheim Pharma GmbH & Co KG: Operational Indicators
Company Background
Production
Summary 15 Boehringer Ingelheim Pharma GmbH & Co KG: Production Statistics 2009
Competitive Positioning
Summary 16 Boehringer Ingelheim Pharma GmbH & Co KG: Competitive Position 2009
Mcm Klosterfrau Vertriebsgesellschaft Mbh
Strategic Direction
Key Facts
Summary 17 MCM Klosterfrau Vertriebsgesellschaft mbH: Key Facts
Summary 18 MCM Klosterfrau Vertriebsgesellschaft mbH: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 19 MCM Klosterfrau Vertriebsgesellschaft mbH: Competitive Position 2009
Medice GmbH & Co Kg
Strategic Direction
Key Facts
Summary 20 Medice GmbH & Co KG: Key Facts
Summary 21 Medice GmbH & Co KG: Operational Indicators
Company Background
Production
Summary 22 Medice GmbH & Co KG: Production Statistics 2009
Competitive Positioning
Summary 23 Medice GmbH & Co KG: Competitive Position 2009
Strategic Direction
Key Facts
Summary 24 Novartis Deutschland GmbH: Key Facts
Summary 25 Novartis Deutschland GmbH: Operational Indicators
Company Background
Production
Summary 26 Novartis Deutschland GmbH: Production Statistics 2009
Competitive Positioning
Summary 27 Novartis Deutschland GmbH: Competitive Position 2009
Ratiopharm GmbH & Co
Strategic Direction
Key Facts
Summary 28 Ratiopharm GmbH & Co: Key Facts
Summary 29 Ratiopharm GmbH & Co: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 30 Ratiopharm GmbH & Co: Competitive Position 2009
Stada Arzneimittel AG
Strategic Direction
Key Facts
Summary 31 STADA Arzneimittel AG: Key Facts
Summary 32 STADA Arzneimittel AG: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 33 STADA Arzneimittel AG: Competitive Position 2009
Trends
Category Data
Table 12 Sales of Wound Treatments by Subsector: Value 2004-2009
Table 13 Sales of Wound Treatments by Subsector: % Value Growth 2004-2009
Table 14 Wound Treatments Company Shares by Value 2005-2009
Table 15 Wound Treatments Brand Shares by Value 2006-2009
Table 16 Forecast Sales of Wound Treatments by Subsector: Value 2009-2014
Table 17 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2009-2014
Expenditure on Consumer Health Slows Down Compared To Previous Years
OTC Obesity Drugs Enter Market
Main Brands Continue To Gain Importance
Distribution Channels Continue To Shift Slowly
Forecast Performance Expected To Remain Sluggish
Key Trends and Developments
Increased Obesity Rates Are Having A Positive Impact on Supplement Sales
Private Label Products Continue To Increase Market Share in Many Categories
Consumer Doubts Impact Sales of OTC Medicine
Increasing Trust in Homoeopathic Remedies Shifts Consumer Demand
European Court of Justice Stops Setting Up of Chemist/pharmacy Chains
Market Indicators
Table 1 Consumer Expenditure on Health Goods and Medical Services 2004-2009
Table 2 Life Expectancy at Birth 2004-2009
Market Data
Table 3 Sales of Consumer Health by Sector: Value 2004-2009
Table 4 Sales of Consumer Health by Sector: % Value Growth 2004-2009
Table 5 Consumer Health Company Shares by Value 2005-2009
Table 6 Consumer Health Brand Shares by Value 2006-2009
Table 7 Penetration of Private Label by Sector 2004-2009
Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2004-2009
Table 9 Sales of Consumer Health by Sector and Distribution Format: % Analysis 2009
Table 10 Forecast Sales of Consumer Health by Sector: Value 2009-2014
Table 11 Forecast Sales of Consumer Health by Sector: % Value Growth 2009-2014
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine (florian)
Switches
Summary 1 OTC Healthcare Switches 2007-2009
Definitions
Sector and Subsector Definitions
Summary 2 Research Sources
Bad Heilbrunner Naturheilmittel GmbH & Co
Strategic Direction
Key Facts
Summary 3 Bad Heilbrunner Naturheilmittel GmbH & Co: Key Facts
Summary 4 Bad Heilbrunner Naturheilmittel GmbH & Co: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 5 Bad Heilbrunner Naturheilmittel GmbH & Co: Competitive Position 2009
Bayer Vital GmbH
Strategic Direction
Key Facts
Summary 6 Bayer Vital GmbH: Key Facts
Summary 7 Bayer Vital GmbH: Operational Indicators
Company Background
Production
Summary 8 Bayer Vital AG: Production Statistics 2009
Competitive Positioning
Summary 9 Bayer Vital GmbH: Competitive Position 2009
Beiersdorf AG
Strategic Direction
Key Facts
Summary 10 Beiersdorf AG: Key Facts
Summary 11 Beiersdorf AG: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 12 Beiersdorf AG: Competitive Position 2009
Boehringer Ingelheim Pharma GmbH & Co Kg
Strategic Direction
Key Facts
Summary 13 Boehringer Ingelheim Pharma GmbH & Co KG: Key Facts
Summary 14 Boehringer Ingelheim Pharma GmbH & Co KG: Operational Indicators
Company Background
Production
Summary 15 Boehringer Ingelheim Pharma GmbH & Co KG: Production Statistics 2009
Competitive Positioning
Summary 16 Boehringer Ingelheim Pharma GmbH & Co KG: Competitive Position 2009
Mcm Klosterfrau Vertriebsgesellschaft Mbh
Strategic Direction
Key Facts
Summary 17 MCM Klosterfrau Vertriebsgesellschaft mbH: Key Facts
Summary 18 MCM Klosterfrau Vertriebsgesellschaft mbH: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 19 MCM Klosterfrau Vertriebsgesellschaft mbH: Competitive Position 2009
Medice GmbH & Co Kg
Strategic Direction
Key Facts
Summary 20 Medice GmbH & Co KG: Key Facts
Summary 21 Medice GmbH & Co KG: Operational Indicators
Company Background
Production
Summary 22 Medice GmbH & Co KG: Production Statistics 2009
Competitive Positioning
Summary 23 Medice GmbH & Co KG: Competitive Position 2009
Strategic Direction
Key Facts
Summary 24 Novartis Deutschland GmbH: Key Facts
Summary 25 Novartis Deutschland GmbH: Operational Indicators
Company Background
Production
Summary 26 Novartis Deutschland GmbH: Production Statistics 2009
Competitive Positioning
Summary 27 Novartis Deutschland GmbH: Competitive Position 2009
Ratiopharm GmbH & Co
Strategic Direction
Key Facts
Summary 28 Ratiopharm GmbH & Co: Key Facts
Summary 29 Ratiopharm GmbH & Co: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 30 Ratiopharm GmbH & Co: Competitive Position 2009
Stada Arzneimittel AG
Strategic Direction
Key Facts
Summary 31 STADA Arzneimittel AG: Key Facts
Summary 32 STADA Arzneimittel AG: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 33 STADA Arzneimittel AG: Competitive Position 2009
Trends
Category Data
Table 12 Sales of Wound Treatments by Subsector: Value 2004-2009
Table 13 Sales of Wound Treatments by Subsector: % Value Growth 2004-2009
Table 14 Wound Treatments Company Shares by Value 2005-2009
Table 15 Wound Treatments Brand Shares by Value 2006-2009
Table 16 Forecast Sales of Wound Treatments by Subsector: Value 2009-2014
Table 17 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2009-2014
